The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice

被引:29
作者
Burns, Ted M. [1 ]
机构
[1] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA
来源
MYASTHENIA GRAVIS AND RELATED DISORDERS I | 2012年 / 1274卷
关键词
MG composite; myasthenia gravis; outcome measures; MGC; MG; MYCOPHENOLATE-MOFETIL; RECOMMENDATIONS; CYCLOSPORINE; RELIABILITY; VALIDATION; STANDARDS; IVIG;
D O I
10.1111/j.1749-6632.2012.06812.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The myasthenia gravis composite (MGC) was constructed by selecting the best performing items from three commonly used, MG-specific scales. The response categories of the items were subsequently weighted for importance. The MGC, which takes less than five minutes to complete, is made up of three ocular, three bulbar, one respiratory, one neck, and two limb items. After its construction, the MGC was validated in an 11-center scale validity study. During the validation study, which included test-retest analysis, it was determined that a 3-point improvement in MGC score reliably indicates clinical improvement. A 3-point improvement in MGC also appears to be meaningful to the patient. Rasch analysis of the MGC confirmed that all 10 items belong and can be summed to provide a total score, and that the weights given to the response categories of the items are appropriate.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 32 条
  • [21] Myasthenia gravis self-administered questionnaire: development of regional domains
    Padua, L
    Galassi, G
    Ariatti, A
    Aprile, I
    Caliandro, P
    Evoli, A
    Pazzaglia, C
    Tonali, P
    [J]. NEUROLOGICAL SCIENCES, 2005, 25 (06) : 331 - 336
  • [22] Psychometric evaluation of the myasthenia gravis composite using rasch analysis
    Sadjadi, Reza
    Conaway, Mark
    Cutter, Gary
    Sanders, Donald B.
    Burns, Ted M.
    [J]. MUSCLE & NERVE, 2012, 45 (06) : 820 - 825
  • [23] An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
    Sanders, D. B.
    Hart, I. K.
    Mantegazza, R.
    Shukla, S. S.
    Siddiqi, Z. A.
    De Baets, M. H. V.
    Melms, A.
    Nicolle, M. W.
    Solomons, N.
    Richman, D. P.
    [J]. NEUROLOGY, 2008, 71 (06) : 400 - 406
  • [24] A simple manual muscle test for myasthenia gravis - Validation and comparison with the QMG score
    Sanders, DB
    Tucker-Lipscomb, B
    Massey, JM
    [J]. MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 440 - 444
  • [25] Sanders DB, 2008, NEUROLOGY, V71, P394, DOI 10.1212/01.wnl.0000312373.67493.7f
  • [26] Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis
    Sharshar, T
    Chevret, S
    Mazighi, W
    Chillet, P
    Huberfeld, G
    Berreotta, C
    Houfani, M
    Gajdos, P
    [J]. JOURNAL OF NEUROLOGY, 2000, 247 (04) : 286 - 290
  • [27] PRELIMINARY-RESULTS OF A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CYCLOSPORINE IN MYASTHENIA-GRAVIS
    TINDALL, RSA
    ROLLINS, JA
    PHILLIPS, JT
    GREENLEE, RG
    WELLS, L
    BELENDIUK, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (12) : 719 - 724
  • [28] A CLINICAL THERAPEUTIC TRIAL OF CYCLOSPORINE IN MYASTHENIA-GRAVIS
    TINDALL, RSA
    PHILLIPS, JT
    ROLLINS, JA
    WELLS, L
    HALL, K
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 681 : 539 - 551
  • [29] Measuring Outcomes And Efficiency In Medicare Value-Based Purchasing
    Tompkins, Christopher P.
    Higgins, Aparna R.
    Ritter, Grant A.
    [J]. HEALTH AFFAIRS, 2009, 28 (02) : W251 - W261
  • [30] Myasthenia gravis activities of daily living profile
    Wolfe, GI
    Herbelin, L
    Nations, SP
    Foster, B
    Bryan, WW
    Barohn, RJ
    [J]. NEUROLOGY, 1999, 52 (07) : 1487 - 1489